/Boston%20Scientific%20Corp_%20logo%20on%20iPad-%20by%20Kate%20Krav-Rude%20via%20Shutterstock.jpg)
Valued at a market cap of $133.6 billion, Boston Scientific Corporation (BSX) develops, manufactures, and markets medical devices for use in various interventional medical specialties. The Marlborough, Massachusetts-based company offers devices to diagnose and treat cardiovascular, respiratory, digestive, oncological, neurological, and urological diseases and conditions.
Companies valued at $10 billion or more are generally described as “large-cap” stocks and Boston Scientific Corporation fits right into that category. The medical device company is known for providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care.